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a stent to withatand pressures generated by coronary arteries during elastic
recoil and variations in vaeomotor tone. We evaluated in vitro the ability of
FlexStent (Cook Cardiology), GR II (a modified form of FlexStentdesign) and
JJIS (Johnson &Johnson) 3.0 and 4.0 mm diameter stents to reaiatexternal
circumferential pressure and determined the threshold for stent collapse.
A device was constructed to evaluate flow (perfusion pressure 90 mmHg)
through silastic tubing containing an expanded stent aa increasing external
prasaurewas applied by a pressure chamber. Triplicate measurements were
made for each stent size and design. Collapse threshold pressure (preasure
at which flow through the stent decreaaad by 10%) end collapse slope were
compared. Results:
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Collapse threshold pressures were statistically higher for GR II 3.0 mm
than other 3.0 mm stents. Collapse pressures for the 4.0 mm group were
significantly different from each other (GR II > JJIS > FlexStent). Collapse
slopes were significantly steeper for FlexStent than GR II or JJIS 3.0 mm (P
< 0.001) and 4.0 mm stents (P= 0.002).
Conclusion:Modifications of the FlexStent design applied in the GR II
stent have increased collapse resistance ai$mificently.This demonstrates
that some flexible stent designs can provide vascular support similar or
superior to that of rigid stent designs.
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The bulk of the atherosclerotic plaque, which is displaced but not removed
by balloon angioplasty (PTCA), opposes to optimal stent expansion and may
limit the success of stent implantation. Directional coronary atheractomy
(DCA), which removes the atherosclerotic plaque, might provide a better
anatomical condition for successful stent implantation. This pilot study eval-
uates the acute results of combining DCA and stent implantation (Palmez-
Schatz) in a consecutive series of 66 patients with angina pectoris un-
dergoing 71 procedures. As controts, we selected patients with the same
inclusionlexclusion criteria, undergoing successful elective stent implanta-
tion (Palmez-Schatz) during the same period matched for lesion site, lesion
location, minimal lesion diameter and anginal status. Results obtained by
quantitative mronary arteriography and statistics are the following:
Variables Pre-DCA post-DCA DCA + STENT
% Stenosis 74.6k 97 24.6 & 9.S” 6.7& 8.8*
Abaolutsgain (mm) 2.44+ 0.56#
Relatlvegaln (%) 62+ 13$
pre-PTCA post-PTCA PTCA + STENT
% Stenosis 75.1 k 7.3 34.3* 12.1 16.8 * 11.4
Absolutsgain (mm) 1.93 + 0.61
Relative gain (%) 53* 14
*p< 0.01 vs peat-PTCA; ‘p < 0.005snd9P < 0.05vsPTCA + STENT.
In conclusion, stent implantation after DCA provides further improvement
of the acute angiographic resulta obtained by DCA alone. The acute gain
obtained by the combination of DCA followed by stent implantation is better
than that obtained by atent implantation alone.
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Purpose:this ongoing prospective study tests the hypothesis that stent-
ing after directional atherectomy (DCA) increasea lumen gain and reduces
restenosis. Methods:33pte (36 lesions) are included in this analysis. Stents
used were (Palmez-Schafz 17, Gianturco-Roubin II 6, other 15). Quantitative
coronary angiogrephy (QCA) and intravascular ultrasound (IVUS) measure-
ments were:
Baseline Post-DCA POat.Stent
QCA RD (mm) 3.21 + 0.52” 3.26 & 0.54 3.50+0s9”
QCA MLD (mm) 0.77* 0,37$ 2.36+ 0.66” 3.48 +OS5*
QCA % DS 76* 11* 28+ 16*018*
QCA LL (mm) 11.12 + 4,72
Vsssel CSA (mm2) 13.15* 4.34 15.11 +4,07
LumenCSA (mn#) 2.89 + 0.88” 8.40 & 2.79* 8.36 +2.08
% Plaque area** 78& 8* 43+ 13*
CSA crosssectionalarea;** 04,Plaque area= (vessel CSA – LumenCSA)hreeeel CSA;
RD, reference diameter; LL, Ieaionlength;*P <0.05.
Procedural success was 97%, one patient had emergency CABG, Ml and
died post surgery. No other pt had CPK rise more than twice of normal. No
other events occurred at 1 month follow-up. Conclusions:1- Stenting after
DCA allowa optimizing lumen gain with acceptable rate of complications. 2-
Six month angiogrephic and clinical outcome will be available at the time of
presentation.
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Experimental studies from our institution have shown absence of thrombosis
and minimal intimal hyperplasia after the autologous vein graft-coated atent
(AVGCS)implantation in peripheral arteries. The immediate resulteof AVGCS
implantation in 36 patients (pts) are pres.entadin this study. Methods:The
right cephalic vein waa isolated and a 3-cm vein graft was removed. A
Palmaz’” or a Palmez-Schatzw stent was either covered completely (both
internally and externally, type A AVGCS) or only externally (type B AVGCS)
by the vein graft. The vein lining(s) was stabilised on the stent by sutures
(Prolene 7-O). Thirty-eight AVGCSS(10 type A, 25 type B) were implanted in
36 pts (54 + 4.6 yre). Indications for AVGCS implantation were as followa: 12
AVGCSSwere placed in totally occluded vessels, 10 for treatment of acute
myocardial infarction (AMI), 9 for elective stenting, and 7 as a bail-out device.
The first 10 consecutive pts and the pts with AMI received anticoegulation.
The rest of the pts left hospital under aspirin and ticlopidine. Results:In all
cases the procedure of both types AVGCS preparation was feasible and
short in duration (< 20 rein). The delive~ and deployment of AVGCS wee
successful and uncomplicated in all pts. The immediate angiogrephic results”
were excellent without any case of thrombosis. Ail pta were discharged
without symptoms. The minimal Iuminal diameter (MLD) waa increased from
0.29 + 0.4 mm to 3.26 + 0.7 mm (n = 35, p < 0.001). In 6 petienta,
an angicgrsphy was performed after 6.1 + 0.4 montha and the MLD was
unchanged (after: 3.24 + 0.3, follow-up: 3.08+ 0.3 mm, p = NS). Conckx+iom
Autologous vein graft-coated stent preparation and implantation is afaaeible
procedure with excellent immediate results. Further studies will evaluate the
indications and long-term efficacy of this technique.
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Inorder toeesesstheroleof the stent length on theshortand mid-term PTCA
results, we retrospectively compared patients receiving coronary stenting
with the Freedom’” stent using 25 mm se a threshold to separate shotl and
long stenting. Clinical and angiographic data were similar but a lower rate of
LAD lesion and a higher rate of occiusion in the long group. All pts received
a ticlopidine/aspirin drug regimen. Results were:
>25 mm <25 mm p
N (pteilesions) t82/190 328/357
Stent length(mm) 18&4 42 t 14 <0,001
Stenfflesionratio 1.28 + 0.5 l.o8 + 0.3 <0.001
Technicalsuccess (%) 84.2 95.5 NS
Proceduralsuccess(%) 98.8 98 NS
Clinicalsuccsas(Or&) 98.3 97.2 NS
Ml (%) t,l 1.5
CABG (%)
NS
o 0.3 NS
Death(OA) o 0.6 NS
Stsntthrombosis(4A) 1.6 1,4 NS
6 monthstsrgst Iats rsvascularieetionrate (%) 16.3 8.7 <0.05
Thus, the stent length does not affect the shorl term reaults but inducea
a higher rate of reintervention. Furlher studies are necessary to accurately
assess the clinical benefit of long stenting compared to plain balloon angio-
plasty.
